Browse All
Displaying 1 - 3 of 3
Author:Williams, Mitzi Airas, Laura Chitnis, Tanuja Saini, Sarbjit Hide, Michihiro Sussman, Gordon Nakahara, Jin Bermel, Robert Dörner, Thomas Loop, Brett Ziehn, Marina Willi, Roman Kieseier, Bernd C. Nikolaev, Ivan Haemmerle, Sibylle Zharkov, Artem Siegel, Richard Cenni, Bruno Wiendl, Heinz Maurer, Marcus Giménez-Arnau, Ana Montalban, Xavier
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.015
Author Institution:Joi Life Wellness Group, Atlanta, GA, USA, Atlanta, GA Turku University Hospital and University, Finland, Turku, Finland Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA, Boston, MA Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA, Baltimore, MD Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, Hiroshima, Japan University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin DRFZ, Berlin, Germany, Berlin, Germany Novartis Pharmaceutical Corporation, Cambridge, MA, USA, Cambridge, MA Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Novartis Pharma AG, Basel, Switzerland Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, Duesseldorf, Germany Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, Berlin, Germany Department of Dermatology, Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain, Barcelona, Spain Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain
Author:Esmaeili, Sara Mirzaasgari, Zahra Mojtahed, Mohammad Zabeti, Aram
Session Name:P7: Cerebrovascular Disease and Interventional Neurology: Thrombolytic Therapy and Acute Stroke Treatments
Topic:Cerebrovascular Disease and Interventional Neurology
Author Institution:Department of Neurology, University of Cincinnati Department of Neurology, Iran University of Medical Sciences
Author:Beck, James Meyer, Zachary Naito, Anna Marras, Connie Weintraub, Daniel Dahodwala, Nabila Spindler, Meredith Davis, Thomas Brown, Amy Miyasaki, Janis Mills, Kelly Nelson, Eugene Neault, Marilyn Mantri, Sneha Allen, Allison
Session Name:P7: Movement Disorders: Parkinson's Disease Non-motor Symptoms 2
Topic:Movement Disorders
Author Institution:Parkinson's Foundation, New York, NY Parkinson's Foundation, Miami, FL Toronto Western Hospital, Toronto, ON, Canada University of Pennsylvania, Philadelphia, PA Vanderbilt University, Nashville, TN University of Alberta, Edmonton, AB, Canada Johns Hopkins University, Baltimore, MD Dartmouth College, Hanover, NH Duke University, Durham, NC Duke University, Cary, NC
